| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/15/1997 | US5648347 Arylmorpholine, preparation and use |
| 07/15/1997 | US5648335 Prevention and treatment of peripheral neuropathy |
| 07/15/1997 | US5648259 Polypeptides having NMDA receptor activity, nucleic acids encoding those polypeptides and applications |
| 07/10/1997 | WO1997024356A1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 07/10/1997 | WO1997024350A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 07/10/1997 | WO1997024348A1 ((3'-thioxacyclohex-1'-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/10/1997 | WO1997024323A1 Process for the preparation of optically enriched 4-aryl-3-hydromethyl substituted piperidines to be used as intermediates in the synthesis of paroxetine |
| 07/10/1997 | WO1997024117A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 07/10/1997 | WO1997024116A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
| 07/10/1997 | DE19544768C1 Verwendung einer Kombination aus Pentoxifyllin mit Typ-I-Interferonen zur Behandlung der Multiplen Sklerose Using a combination of pentoxifylline with type I interferons for the treatment of multiple sclerosis |
| 07/10/1997 | CA2241758A1 Methods of treatment with compounds having rar.alpha. receptor specific or selective activity |
| 07/10/1997 | CA2240401A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/09/1997 | EP0782857A1 Remedy and preventive for nervous system disorder |
| 07/09/1997 | EP0782627A1 Genetically altered t-cells |
| 07/09/1997 | EP0782574A1 Bicyclic carboxamides as 5-ht 1a? antagonists |
| 07/09/1997 | EP0782573A1 Drugs to improved synaptic transmission |
| 07/09/1997 | EP0782568A1 Aromatic ethers derived from indols such as 5ht1-like ligands |
| 07/09/1997 | EP0782567A1 Isothiourea derivatives as no synthase inhibitors |
| 07/09/1997 | EP0782445A1 Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
| 07/09/1997 | EP0782441A1 Pharmaceutical control of inflammation |
| 07/09/1997 | EP0720602B1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents |
| 07/09/1997 | EP0681580B1 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| 07/09/1997 | CN1154107A Serotonin 5-HT1A and dopamin D2 receptor ligands |
| 07/08/1997 | US5646313 Preparing enkephalinase inhibitors |
| 07/08/1997 | US5646309 Serotonin receptor antagonists; central nervous system disorders |
| 07/08/1997 | US5646300 Neuroprotective agents |
| 07/08/1997 | US5646289 Reacting a 3-chloro-1,2,5-thiadiazole with alkali metal bis(trialkyl or arylsilyl)amide; dechlorination; treating nervous system disorders |
| 07/08/1997 | US5646180 Treatment of the CNS effects of HIV |
| 07/08/1997 | US5646173 Tricyclic pyrrole derivatives useful as 5-HT selective agents |
| 07/08/1997 | US5646166 Use of 5-acyl-1,4-dihydropyridines |
| 07/08/1997 | US5646161 Side effect reduction; sustained release |
| 07/08/1997 | US5646152 Treating psychological disorders with corticotropin releasing factor antagonists |
| 07/08/1997 | US5646151 For treatment of hyperalgesia |
| 07/08/1997 | US5646146 Heterocyclic compounds and their preparation and use |
| 07/08/1997 | US5646144 For treating disorders in which substance p plays a part in development |
| 07/08/1997 | US5646143 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 07/08/1997 | US5646132 2(1H)-quinolone compounds |
| 07/08/1997 | US5646032 Recombinant foamy virus vectors for medicinal, and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/08/1997 | US5645857 Pharmaceutical composition having analgesic activity |
| 07/08/1997 | CA2057913C N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 07/03/1997 | WO1997023613A2 Cell activation process and reagents therefor |
| 07/03/1997 | WO1997023494A1 Carbohydrate conjugated bio-active compounds |
| 07/03/1997 | WO1997023485A1 Heteroarylcarboxamide derivatives |
| 07/03/1997 | WO1997023482A1 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives |
| 07/03/1997 | WO1997023481A1 Trans apovincaminic acid ester derivatives as drugs |
| 07/03/1997 | WO1997023467A1 Novel compounds with analgesic effect |
| 07/03/1997 | WO1997023466A1 Novel compounds with analgesic effect |
| 07/03/1997 | WO1997023220A1 Method for treating depression |
| 07/03/1997 | WO1997023218A1 A process for regulating vagal tone |
| 07/03/1997 | WO1997023214A1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| 07/03/1997 | WO1997015300A3 Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for prophylaxis and treatment of sequelae of acute and chronic reduced circulation in the brain and neurodegenerative disorders |
| 07/03/1997 | CA2241153A1 Method for treating depression |
| 07/03/1997 | CA2240038A1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| 07/03/1997 | CA2239162A1 Novel compounds with analgesic effect |
| 07/03/1997 | CA2238873A1 Cell activation process and reagents therefor |
| 07/03/1997 | CA2238635A1 Trans apovincaminic acid ester derivatives as drugs |
| 07/03/1997 | CA2213489A1 Carbohydrate conjugated bio-active compounds |
| 07/02/1997 | EP0781766A1 Heterocyclic derivative and medicine |
| 07/02/1997 | EP0781558A2 Pharmaceutical use of heparin cofactor II |
| 07/02/1997 | EP0781556A1 Use of condensed dihydropyridines for the treatement of chronic inflammatory processes |
| 07/02/1997 | EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents |
| 07/02/1997 | EP0781546A1 A multi-layered film preparation |
| 07/02/1997 | EP0781335A1 Cloning and characterizing of genes associated with long-term memory |
| 07/02/1997 | EP0781297A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
| 07/02/1997 | EP0781285A1 Fused indole and quinoxaline derivatives, their preparation and use |
| 07/02/1997 | EP0781284A1 Indole-2,3-dione-3-oxime derivatives, their preparation and use |
| 07/02/1997 | EP0781282A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE |
| 07/02/1997 | EP0781281A1 NOVEL MELATONIN AGONIST $g(b)-CARBOLINE DERIVATIVES AND ANALOGS WITH A NAPHTHALENIC STRUCTURE, METHOD FOR THEIR PREPARATION AND THEIR USE AS DRUGS |
| 07/02/1997 | EP0781279A1 Quinoxalinedione nmda receptor antagonists |
| 07/02/1997 | EP0781143A1 Method of blocking the sec receptor |
| 07/02/1997 | EP0781137A1 Novel compositions containing phosphoglycero ethers, and use thereof for treating neurodegenerative diseases |
| 07/02/1997 | EP0781127A1 Anaesthetic analgesic gas mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane |
| 07/02/1997 | EP0632806B1 Aminocyclohexylamides for antiarrhythmic and anaesthetic uses |
| 07/02/1997 | EP0527757B1 Composition and methods for treatment of acne vulgaris and retardation of ageing |
| 07/02/1997 | EP0522082B1 Multi-functional pharmaceutical compounds and methods of use |
| 07/02/1997 | CN1153528A Pantropic neurotrophic factors |
| 07/02/1997 | CN1153517A Quinoxalindione derivs., their preparation and their use in drugs |
| 07/02/1997 | CN1153510A Amide derivs. and their therapeutic use |
| 07/02/1997 | CN1153045A Epilepsy pill and producing process thereof |
| 07/01/1997 | US5644055 Cyclization of indole or quinoline compound, enzyme inhibitors, treatment of cardiovasacular disorders |
| 07/01/1997 | US5643954 Stress resistance or nootropic effect using glycine and methyl cellulose in tablet form |
| 07/01/1997 | US5643938 Pyrazolopyridine compounds for the treatment of anemia |
| 07/01/1997 | US5643932 Superoxide radical inhibitor |
| 07/01/1997 | US5643930 6-heterocyclic-4-amino-1,3,4,5,-tetrahydrobenz [cd]indoles |
| 07/01/1997 | US5643927 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia |
| 07/01/1997 | US5643925 Benzene derivatives having NGF production-promoting activity |
| 07/01/1997 | US5643923 Treatment of anxiety, cognition activators, senility or alzheimer's |
| 07/01/1997 | US5643917 4-aminomethyl-1-azaadamantane derived benzamides |
| 07/01/1997 | US5643907 Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of CNS disorders |
| 07/01/1997 | US5643905 Pharmaceutical formulation for the treatment of nicotine dependence |
| 07/01/1997 | US5643893 Antiinflammatory agents or antiarthritic agents |
| 07/01/1997 | US5643778 RNA editing enzyme and methods of use thereof |
| 07/01/1997 | US5643749 Soluble interferon α-receptor, its preparation and use |
| 07/01/1997 | US5643598 Method of skin care utilizing liposomes containing Scutellaria extracts |
| 07/01/1997 | CA2128248C Amino acids useful as inhibitors of the advanced glycosylation of proteins |
| 06/26/1997 | WO1997022695A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | WO1997022619A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022606A1 Morphine derivatives with analgesic activity |
| 06/26/1997 | WO1997022597A1 Piperazine derivatives as tachykinin antagonists |